CHM Cannabis
Home > Boards > US Listed > Biotechs >

Viking Therapeutics, Inc. (VKTX)

Add VKTX Price Alert      Hide Sticky   Hide Intro
Moderator: DMOST, greens12
Search This Board: 
Last Post: 12/10/2018 11:29:12 PM - Followers: 69 - Board type: Free - Posts Today: 0

Novel therapeutics for metabolic<Br/>and endocrine disorders
  1. 2


Viking Therapeutics is focused on the development of novel therapeutics for patients suffering from metabolic and endocrine disorders.

Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s research and development activities leverage the Company’s expertise in metabolism to develop innovative therapeutics that improve patients’ lives. The Company’s lead clinical program is VK5211, an orally available, non-steroidal selective androgen receptor modulator, or SARM, for the treatment of patients recovering from non-elective hip fracture surgery. The Company’s second program is focused on the development of first-in-class, selective, small molecule agonists of the thyroid receptor beta, or TRß, for adrenoleukodystrophy, or ALD, and lipid disorders such as hypercholesterolemia and non-alcoholic steatohepatitis, or NASH. Viking is also developing additional programs targeted at diabetes, metabolic diseases and anemia.



We have a portfolio of five drug candidates in clinical trials or preclinical studies

Our lead clinical program, VK5211, is a novel, orally available, non-steroidal selective androgen receptor modulator, or SARM, in development for the treatment of patients recovering from non-elective hip fracture surgery. VK5211 is designed to produce the therapeutic benefits of testosterone in muscle and bone with improved safety, tolerability and patient acceptance. We have initiated a Phase 2 clinical trial with VK5211 in patients recovering from non-elective hip fracture surgery. For more information on this study please visit NCT02578095.

Our second pipeline program is focused on the development of novel small molecule agonists of the thyroid beta (TRb) receptor, VK2809 and VK0214. These novel TRb agonists are being developed for hypercholesterolemia and fatty liver disease and X-linked adrenoleukodystrophy, or X-ALD. We have initiated Phase 2 clinical development of VK 2809 in hypercholesterolemia and fatty liver disease. VK0214 is in preclinical development for X-ALD.

We are also developing VK0612, a first-in-class, orally available drug 

CHM Cannabis
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VKTX News: Amended Statement of Beneficial Ownership (sc 13d/a) 11/13/2018 05:05:00 PM
VKTX News: Viking Therapeutics Presents Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) ... 11/12/2018 06:55:00 PM
VKTX News: Quarterly Report (10-q) 11/07/2018 05:06:23 PM
VKTX News: Current Report Filing (8-k) 11/07/2018 04:28:42 PM
VKTX News: Viking Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update 11/07/2018 04:05:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#1675  Sticky Note Viking Has A More Attractive M&A Valuation Than DMOST 11/20/18 09:57:00 AM
#1687   Viking Therapeutics, Inc. (VKTX) ......Weakening support. DMOST 12/10/18 11:29:12 PM
#1686   Here's Why Madrigal Pharmaceuticals Fell 39.4% in November DMOST 12/08/18 10:46:50 PM
#1685   Viking Therapeutics, Inc. (VKTX) ................Well a " C DMOST 12/02/18 01:26:27 AM
#1684   Maybe. Most likely. However, I don’t expect anything gblxwhale 12/01/18 06:48:53 PM
#1683   Why Sure . DMOST 12/01/18 02:53:17 AM
#1682   Any chance you could elaborate for those who Sncgolf03 11/30/18 11:49:42 PM
#1681   VKTX ................ Primed . DMOST 11/30/18 08:35:14 PM
#1680   Partnership or possible Buyout is next. You have greens12 11/29/18 01:01:05 PM
#1679   Tell me about it. Sold on run up, gblxwhale 11/28/18 02:23:48 PM
#1678   I was planning on holding tight but it's Sncgolf03 11/28/18 01:59:25 PM
#1677   Ignore the article. We sitting on 2 blockbuster gblxwhale 11/28/18 01:44:21 PM
#1676   Any thoughts on the latest seeking alpha article Sncgolf03 11/28/18 08:32:15 AM
#1675   Viking Has A More Attractive M&A Valuation Than DMOST 11/20/18 09:57:00 AM
#1674   Short interest is a whopping 36% > That's crudeoil24 11/19/18 09:05:00 AM
#1673 girlfriend 11/19/18 08:59:05 AM
#1672   Viking Therapeutics upgraded to strong buy from outperform crudeoil24 11/19/18 08:57:46 AM
#1671   That would be great........... VKTX . DMOST 11/15/18 09:24:42 PM
#1670   VKTX & MDGL is still in trial phase DMOST 11/15/18 09:22:57 PM
#1669   When vk2809 Biopsy data comes in it will greens12 11/15/18 06:04:52 PM
#1668   hi when would we see approval for MDGL peterus 11/15/18 10:14:01 AM
#1667   Better NASH Stock: Madrigal Pharmaceuticals, Inc. vs. Viking DMOST 11/15/18 03:26:35 AM
#1666   MDGL also down huge. I just added girlfriend 11/14/18 10:43:34 AM
#1665   Thank you...curious and agree. I am fairly girlfriend 11/14/18 08:52:26 AM
#1664   Not enough funds to do so...........They did loan DMOST 11/14/18 08:42:13 AM
#1663   Is Ligand going to buy out VKTX at girlfriend 11/14/18 08:16:21 AM
#1662   Viking Therapeutics Shows How Quickly This Market Can Turn DMOST 11/14/18 08:13:49 AM
#1661   Today’s Research Reports on Stocks to Watch: Viking DMOST 11/14/18 08:05:41 AM
#1660   In VKTX here at 11.56 girlfriend 11/13/18 03:20:13 PM
#1659   featured LivH 11/13/18 02:26:11 PM
#1658   Why Viking Therapeutics Stock Is Bolting Higher Today DMOST 11/13/18 09:46:01 AM
#1657   .....Yet, look where VKTX share price is compared DMOST 11/12/18 10:07:28 PM
#1656   VKTX P2 study had better results than MDGL. greens12 11/12/18 08:56:01 PM
#1655   VKTX , of interest....Is the share offering / selling ove DMOST 11/07/18 07:21:23 PM
#1654   Why Viking Therapeutics Stock Sank in October DMOST 11/07/18 10:46:26 AM
#1652   Someone(s) keep selling the share price down?...…. Ligand Pharmaceuticals DMOST 11/05/18 08:10:27 AM
#1651 About Viking Therapeutics, Inc. DMOST 11/04/18 06:11:51 AM
#1650   ...Among others as well. If, they can get DMOST 10/28/18 07:12:49 AM
#1649   I think Gilead Sci. wants to Buyout VKTX greens12 10/27/18 05:51:16 PM
#1648   Exercise price $1.50. 5 year options. Believe they bigjake 10/26/18 10:17:28 AM
#1647   An outstanding bargain DMOST 10/26/18 04:54:34 AM
#1646   Does anyone know the terms (expiry and exercise nsomniyak 10/25/18 02:25:13 PM
#1645   Well said. FWIW, I added more today. It kris_kade 10/22/18 09:41:55 PM
#1644   There was a huge offering last month at greens12 10/22/18 08:02:18 PM
#1643   I am also concerned. Lack of any IRAHopeful 10/22/18 10:36:06 AM
#1642   I think we may even see 10 if ShawnTrade 10/22/18 10:34:38 AM
#1641   Its been down 90% of the last two ShawnTrade 10/22/18 10:03:04 AM
#1640   LOL Touche. That is true. My irritation ShawnTrade 10/19/18 11:39:25 PM
#1639   NASH Opportunity Driving Growth for Viking Therapeutics in 2018 DMOST 10/19/18 04:13:49 PM
#1638   Viking Therapeutics: A Valuation greens12 10/19/18 11:14:01 AM
#1637   Lol...well said. kris_kade 10/18/18 06:33:11 PM